On the Record · Accendra Health

Accendra Health acquisitions, on the record

The businesses Accendra Health bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

Business	Deal	When	Value
Apria, Inc. (Apria) Word for word“On March 29, 2022 (Acquisition Date), we completed the acquisition of 100% of Apria, Inc. (Apria) pursuant to the Agreement and Plan of Merger dated January 7, 2022 (Apria Acquisition), in exchange for approximately $1.7 billion, net of $144 million of cash acquired.” 10-K for 2023	acquisition	March 29, 2022	approximately $1.7 billion, net of $144 million of cash acquired
Products & Healthcare Services segment Word for word“On February 28, 2025, we announced that we are actively engaged in discussions regarding the potential sale of our Products & Healthcare Services segment.” 10-K for 2024	agreed divestiture	—	—
Rotech Healthcare Holdings Inc. Word for word“On July 22, 2024, we entered into an Agreement and Plan of Merger to acquire Rotech Healthcare Holdings Inc., (Rotech) for $1.36 billion in cash.” 10-K for 2024	agreed acquisition	On July 22, 2024	$1.36 billion in cash
Apria, Inc. Word for word“On March 29, 2022 (Apria Acquisition Date), we completed the acquisition of 100% of Apria, Inc. (Apria) pursuant to the Agreement and Plan of Merger dated January 7, 2022 (Apria Acquisition), in exchange for approximately $1.7 billion, net of $144 million of cash acquired.” 10-K for 2024	acquisition	On March 29, 2022	approximately $1.7 billion, net of $144 million of cash acquired
corporate headquarters Word for word“partially offset by $103 million in proceeds related to the sale and disposal of property and equipment, which included sales of patient service equipment and $34 million in gross proceeds related to the sale of our corporate headquarters” 10-K for 2024	divestiture	—	$34 million in gross proceeds
Products & Healthcare Services (P&HS) business Word for word“On December 31, 2025, we completed the sale of the P&HS business pursuant to the Purchase Agreement.” 10-K for 2025	divestiture	On December 31, 2025	—

As filedReported in the company's financial data (XBRL), each linked to its filing
Fiscal year ended	Cash paid for acquisitions (net of cash acquired)	Cash received from selling businesses	Goodwill from acquisitions
2016-12-31	$0	—	—
2017-12-31	$366.6 million	—	$288.7 million
2018-12-31	$751.8 million	—	$125.4 million
2019-12-31	$0	$0	—
2020-12-31	$0	$133 million	—
2021-12-31	$0	$0	$2.8 million
2022-12-31	$1.68 billion	$0	$1.25 billion
2023-12-31	$0	—	$559,000
2025-12-31	$18.1 million	—	—

Deal filings since 2016

2026-08-10 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2026-06-15 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2026-05-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2025-12-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2025-12-31 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2025-10-07 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2025-06-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2025-04-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-10-22 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-07-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2022-03-29 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2022-03-29 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2022-01-10 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2021-03-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-06-18 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2020-04-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-02-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-02-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-02-19 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-05-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-05-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-05-01 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2017-11-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-11-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-07-28 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement

Read from Accendra Health’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.